Private Equity Interest in the Dialysis Sector Continues to Thrive

Geoff Cockrell and I recently co-authored an article on private equity investments in the dialysis sector in Law360 (a LexisNexis legal publication). A copy of the article is attached here .

One of the featured dialysis companies with private equity Continue Reading

DaVitas Purchase of HealthCare Partners Continues Trend of Dialysis Provider Expansion of Services to Renal Patients

Weve discussed in prior posts the multiple waves of heavy dialysis industry consolidation, but another fascinating aspect of the industrys expansion is through the largest providers (LDOs) expansion into dialysis-related services and even into treatment of patients with no renal Continue Reading

Private Equity Investing in the Dialysis Sector Part III (Overseas Investing)

As we round out our series on private equity investing in dialysis, we note an emergence in overseas dialysis investing by U.S. investors. Our blog typically focuses on U.S. investing but cant help but note the interest in overseas Continue Reading

Private Equity Investing in the Dialysis Sector Part II

Part II of our series on private equity investing in dialysis discusses other dialysis companies backed by private equity and highlights some key considerations for investors and companies.

Funded in 2000, U.S. Renal Care (USRC). is another dialysis company Continue Reading

Private Equity Investing in the Dialysis Sector Part I

Private equity investors have been active in the dialysis sector for decades. In Part I of this series on dialysis investments, we describe the recent emergence of three companies with private equity backing.

Two Key Updates in the Dialysis Bundled Payment System

We have discussed in several prior posts the conversion to the Medicare bundled payment system for dialysis facilities which began January 1, 2011. Dialysis facilities had the option of either opting in fully to the new system starting this year or Continue Reading

Dialysis Facilities Poised to Make Decision on Medicare ESRD Bundling Opt In Opportunity by November 1st

U. S. dialysis providers are completing their final analyses this week as the November 1st deadline to fully opt in to the new Medicare bundling reimbursement methodology approaches. Pursuant to the new bundling rule released on July 23, 2010, providers who Continue Reading

How Will Proposed New Quality Improvement Program (QIP) Requirements Impact Dialysis Provider Reimbursement?

On July 23 rd. at the same time that it released the final rule relating to the new bundled payment methodology for renal dialysis providers, CMS issued a proposed rule that would create a new Quality Incentive Program (QIP) Continue Reading

CMS Issues Long Awaited Bundling Rule for Renal Dialysis Providers

Yesterday, CMS issued a release regarding the much anticipated final rule laying out the new bundled prospective payment system (PPS) for renal dialysis facilities. The rule itself was published on July 23, 2010. Under the new PPS. CMS will make a single bundled Continue Reading

Key Issues re Investment in the Dialysis Industry

On Wednesday, March 12 th. McGuireWoods hosted our 8 th Annual Business & Legal Issues in Dialysis & Nephrology Symposium. Leaders from various perspectives in the industry provided presentations and lead discussions on a wide array of topics, including the Continue Reading

Due Diligence on Dialysis and Physician Practice Management Investments

On March 25th McGuireWoods hosted a webinar for private equity investors that provided an overview of key business issues and due diligence process for investments in the dialysis and physician practice spaces. If you missed the webinar, an archived copy Continue Reading

Do Physician Practice Management Companies (PPMCs) Provide Sound Investment Opportunities?

As physicians face the reality of consolidation in certain segments of the healthcare industry, rising costs such as the costs of malpractice coverage, the tangible and intangible costs of administering a private practice and the critical importance of power in the Continue Reading

McGuireWoods — Relationships That Drive Results

Amber Walsh

Amber focuses on corporate healthcare transactional work and regulatory matters. Her experience includes representation of various types of healthcare providers including hospitals, health systems, dialysis facilities, multi- and single-specialty medical practices, specialty hospitals, ambulatory surgery centers, and a variety of healthcare industry entrepreneurs, in sales and acquisitions, joint ventures, general corporate matters, contracting, securities, and regulatory matters.